ReviewAdvances in neurobiology2025
Neuroprotective and Neurotrophic Effects of Astaxanthin on the Brain.
Review in Advances in neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Oxidative Stress, Antioxidant Cofactor Micronutrients, and Cognitive Outcomes in Childhood Obesity: Mechanisms, Evidence, and Therapeutic Opportunities.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxidative stress in the brain is associated with the development and progression of neurological disorders, posing antioxidant nutrients as an effective strategy for protecting neuronal cells and potentially slowing cognitive decline. Bioactive compounds from natural sources with antioxidant effects promote brain health. Among various natural compounds, astaxanthin (ASX), a potent red-pigment carotenoid found in various microorganisms and marine animals, is well recognized for its potential health benefits. In this review, we highlight the promising neuroprotective effects of ASX through cellular experiments and animal models. This review can provide novel insights on the therapeutic potential of ASX through its antioxidant, anti-inflammatory, and anti-apoptotic effects against neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. In addition to demonstrating the neurotrophic effects of ASX on structural and functional changes in hippocampal neuronal plasticity, this review also discusses its synergistic potential with other interventions, such as exercise.
Indexed as
Identifiers
41004107What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.